首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >A potential bio‐control agent from baical skullcap root against listeriosis via the inhibition of sortase A and listeriolysin O
【2h】

A potential bio‐control agent from baical skullcap root against listeriosis via the inhibition of sortase A and listeriolysin O

机译:可能通过抑制分选酶A和李斯特菌溶血素O阻止黄skull根部抗李斯特菌病的生防菌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Listeria monocytogenes (LM) is a classical model intracellular pathogen and the leading cause of listeriosis, which has long been a global public health issue. The successful infection of LM is related to a series of virulence factors, such as the transpeptidase enzyme sortase A (SrtA) and listeriolysin O (LLO), which are crucial for bacterial internalization and escape from phagosomes respectively. It is speculated that targeting multiple virulence factors may be due to a synergistic effect on listeriosis therapy. In this study, an active flavonoids component of Scutellaria baicalensis Georgi, baicalein, was found to potently block both listerial SrtA catalyzed activity and LLO hemolytic activity within 16 μg/mL. After pretreatment with baicalein, 86.30 (±11.35) % of LM failed to associate with Caco‐2 cells compared to the LM without preincubation (regarded as 100% internalization). Furthermore, baicalein addition may aid in bacterial degradation and clearance in macrophagocytes. During a 5 h observation, LM in cells incubated with baicalein showed significantly decreased vacuole escapes and sluggish endocellular growth. In addition, baicalein directly prevented LM‐induced cells injury and mice fatality (survival rate from 10.00% to 54.55% in 4 days post‐intraperitoneal injection). Taken together, as an antagonist against SrtA and LLO, baicalein can be further developed into a biotherapeutic agent for listeriosis.
机译:单核细胞增生李斯特菌(LM)是经典的模型细胞内病原体,也是李斯特菌病的主要原因,而李斯特菌病一直是全球公共卫生问题。 LM的成功感染与一系列毒力因子有关,例如转肽酶分选酶A(SrtA)和李斯特菌溶血素O(LLO),它们分别对细菌内化和从吞噬体逃逸至关重要。推测靶向多种毒力因子可能是由于对李斯特菌病治疗的协同作用。在这项研究中,发现黄cut中的活性黄酮成分黄ical素能在16μg/ mL范围内有效阻断李斯特菌SrtA催化的活性和LLO的溶血活性。与未进行预孵育的LM相比,用黄ical素预处理后,有86.30(±11.35)%的LM无法与Caco-2细胞缔合(被视为100%内在化)。此外,添加黄ical素可以帮助细菌降解和清除巨噬细胞。在5小时的观察过程中,与黄e素温育的细胞中的LM显示液泡逃逸和细胞内生长缓慢明显减少。此外,黄ical素可直接预防LM诱导的细胞损伤和小鼠死亡(腹膜内注射后4天内存活率从10.00%至54.55%)。作为一种针对SrtA和LLO的拮抗剂,黄ical素可以进一步发展成为李斯特菌病的生物治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号